Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.1004 per EA under NDC 51224012160. Its NADAC has been published 296 times since Jul 10, 2019.
Strength
800 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224012160
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207057On Market Since
5/1/2019
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 296 times since Jul 10, 2019, and over the history we have for it it has declined 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1004 per EA |
|---|---|
| All-time high | $0.1374 (Jan 15, 2020) |
| All-time low | $0.0799 (Nov 20, 2024) |
| Median price | $0.1255 |
| Average price | $0.1223 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 296 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 20 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by TAGI Pharma Inc., is $0.1004 per EA (NDC 51224012160), effective Mar 5, 2025.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 22.6%. It has been tracked across 296 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Jul 10, 2019, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1374 (Jan 15, 2020), with a median of $0.1255 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
Yes. 20 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 800 MG TABLET, is $0.0963 per EA — about 4% below GABAPENTIN 800 MG TABLET.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 51224012160) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification